Reset Password
Reset Link Sent
| Blogs > Tropical_Man > Meriam's Guy |
|
FDA orders suicide/homicide warnings for 18-24 yr-olds on SSRI antidepressants: FDA orders suicide/homicide warnings for 18-24 yr-olds on SSRI antidepressants: As the killings and suicides continue at dozens per day, the drug-company-funded FDA has quietly asked SSRI drug manufacturers to extend their black box suicide/homicide warning label to apply to 18-24 year olds in addition to and teens, even though older populations also show increased risk. This comes almost 6 months after the FDA Advisory Board recommendation and 2 years after the first FDA black box order for and teens. (Countercurrents.o, May 2007) |
|||
|
FDA forces ADHD drug manufacturers to give patients literature describing side effects: On February 21, 2007, the FDA "directed the manufacturers of all drug products approved for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) to develop Patient Medication Guides to alert patients to possible cardiovascular risks and risks of adverse psychiatric symptoms associated with the medicines, and to advise them of precautions that can be taken." Last year, the FDA directed ADHD drug companies to update their product labeling with these risks, which include high blood pressure, heart failure, stroke, sudden death, hearing voices, becoming suspicious for no reason, and becoming manic. (FDA, February 21, 2007)
| ||
|
UK's GlaxoSmithKline hides Seroxat (Paxil) suicidal side effect from FDA, doctors and public: Court cases have made previously confidential internal drug company correspondence public information, exposing hidden truths about their drugs' safety and effectiveness. The latest of these cases exposed the UK's GlaxoSmithKline for hiding the sevenfold increase in risk of suicidal and violent behavior in children taking Seroxat (Paxil) from the FDA, doctors and the general public. Panorama states, "Secret e-mails reveal that the UK's biggest drug company distorted trial results of an anti-depressant, covering up a link with suicide in teenagers. Panorama reveals that GlaxoSmithKline (GSK) attempted to show that Seroxat worked for depressed children despite failed clinical trials. And that GSK-employed ghostwriters influenced 'independent' academics." (BBC, January 29, 2007
| ||
|
Zyprexa Maker Eli Lilly Settles with 28,500 victims for $1.2 Billion to date: Since Zyprexa's introduction in 1996, Eli Lilly has paid out $1.2 Billion--yes, that's Billion--in settlement claims to a whopping 28,500 victims of the drug's major and life-threatening side effects including high blood sugar, weight gain and diabetes. But with annual sales of $4.2 Billion, $100 million a year in claim payouts doesn't worry Lilly. What does worry the drug company is the incriminating, image-tarnishing evidence used in these trials that has been made public despite lawyer protective orders and confidentiality agreements signed by victims. (New York Times, January 5, 2007)
| ||
|
ADHD Drugs Sending Thousands to Hospital ERs: In February, the FDA’s Advisory Committee recommended label warnings for all ADHD Drugs (Ritalin, Adderall, Concerta, Dexedrine, Cylert, etc.), warning of high blood pressure, heart failure, stroke and sudden death in children and adults taking these Drugs. The next month, the FDA ignored its own advisory committee’s advice, and the cries of unsuspecting victims continue to sound from ERs across the country. According to a recent CDC study, 3,100 ADHD Drug users visit hospital ERs each year in the U.S. Causes range from side effects like chest pain, stroke, high blood pressure and fast heart rate, to overdose and accidental use–not surprising, considering most ADHD Drugs are a legal form of speed. (ABC News, May 24, 2006)
|
×
×